Nyxoah announced today that it closed a series of financings that amount to up to approximately $77 million in proceeds.

Daybreak, a provider of fully at-home sleep apnea diagnosis and treatment, has named Robert Miller, RPSGT, as its new senior vice president of commercial strategy.

Inspire Medical Systems, Inc. is now grappling with a proposed class-action lawsuit alleging the company misled investors about the commercial readiness and demand for its critical "next generation" ...

In "Don't Sleep on OSA," O'Neal discusses symptoms like "breathing interruptions during sleep... and daytime fatigue." ...

Q3 2025 Earnings Call Transcript November 13, 2025 Nyxoah S.A. misses on earnings expectations. Reported EPS is $-0.74 EPS, ...

Wasatch highlights Q3 winners Medpace, Fabrinet, and Nova, while exiting Inspire. See how conviction, AI exposure, and ...

INSIDE INFORMATION REGULATED INFORMATION Nyxoah Secures Financing Commitments of up to U.S. $77 Million to Drive U.S. Commercialization of Genio ...

CMS is expanding coverage for remote patient monitoring in its 2026 Medicare Physician Fee Schedule, while a major payer is scaling back reimbursement to two specific use cases.

Neurotechnology startup REMspace is preparing to launch SomnoAI, the first AI interface for human sleep. Trained on unique sleep-stimulus data, it's designed to improve sleep quality, predict sleep ...

REGULATED INFORMATION Nyxoah Reports Third Quarter 2025 Financial and Operating Results US launch off to a strong start. First commercial Genio implants completed with widespread payer coverage drives ...

Explore the Wasatch U.S. Select Fund's Q3 2025 results, including underperformance vs. its benchmark and analysis of key ...

Building a medtech startup is a long, costly, and often unforgiving journey. Most don’t make it past five years ...